How do you find using the New Zealand Gazette? Please give your feedback by completing this survey.

Notice Type
Departmental
Consent to the Distribution of Changed New Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Paracetamol 500 mg Tablet Douglas Pharmaceuticals Limited, Mount Roskill, Auckland Guaiphenesin 100 mg, pseudoephedrine hydrochloride 30 mg Capsule (liquid filled) R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia Actifed CC Chesty Dextromethorphan hydrobromide 10 mg, pseudoephedrine hydrochloride 30 mg Capsule (liquid filled) R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia Actifed CC Dry Cyproterone acetate 100 mg Tablet Schering AG, Wedding Plant, Berlin, Germany Androcur-100 Verapamil hydrochloride 180 mg Tablet (modified release) Knoll AG, Ludwigshafen, Germany Isoptin SR 180 Lamotrigine 5 mg, 25 mg, 100 mg Tablets (chewable/ dispersible) The Wellcome Foundation Limited, Temple Hill, Dartford, Kent, United Kingdom Lamictal Dated this 8th day of December 1995. KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.
Publication Date
14 Dec 1995

Notice Number

1995-go8289

Page Number

4774